Table 2.

Proportion of M-RH WITH Selected Underlying Conditions Listed, United States, 2000–2013

Underlying Condition	Crude Proportion of M-RH With the Condition in 2000	Crude Proportion of M-RH With the Condition in 2013	P Valueb
Hematologic malignancy	21.7	38.4	.002
Solid organ transplant	5.8	13.9	.02
Hematopoietic stem cell transplanta	8.5	10.6	.04
Diabetes only	45.8	25.0	.02

Abbreviations: HCUP, Healthcare Cost and Utilization Project; HSCT, hematopoietic stem cell transplant; IA-RH, invasive aspergillosis-related hospitalizations; M-RH, mucormycosis-related hospitalizations.

^aStarts in 2001 because data for mucormycosis and HSCT were limited for the year 2000, and HCUP data use agreement restrict reporting in these instances.

^b P value corresponds to logistic regression using survey analysis to test for significant change in underlying conditions among M-RH over time.